Continuous peripheral nerve block catheters market seen reaching $0.62 billion by 2030

The market for continuous peripheral nerve block catheters is projected to grow from $0.49 billion in 2026 to $0.62 billion by 2030, according to The Business Research Company. Demand is being driven by more orthopedic procedures, rising chronic disease burden and wider use of opioid-sparing pain management after surgery.

Why it matters: - Continuous peripheral nerve block catheters are becoming more important in post-surgical and chronic pain care because they deliver targeted, sustained pain relief. - The market is forecast to expand at a 6.2% CAGR through 2030, signaling steady demand across hospitals, outpatient centers and regional anesthesia settings. - Growth matters for care teams trying to reduce opioid use while improving recovery after surgery.

What happened: - The Business Research Company projected the global continuous peripheral nerve block catheters market will rise from $0.49 billion in 2026 to $0.62 billion by 2030. - The firm said the market was $0.46 billion in 2025 and is expected to reach $0.49 billion in 2026, after growing at a 6.0% CAGR in the historical period. - The report was published July 1, 2026. - The company also offered a free sample of the market report and the full market report.

The details: - Continuous peripheral nerve block catheters are thin, flexible tubes placed near a peripheral nerve or nerve bundle to deliver local anesthetics over time. - The devices block nerve signals from reaching the brain and are used in regional anesthesia, especially after surgery and for chronic pain management. - Orthopedic surgery volumes are a major driver of demand because procedures such as knee and hip replacements often require extended postoperative pain control. - The CORE Institute reported in September 2025 that about 30.5 million orthopedic surgeries were performed worldwide in 2024, up 4.5% from the prior year. - Rising chronic disease prevalence is also supporting adoption because conditions including cancer, diabetes, arthritis, cardiovascular disease and neurological disorders often require prolonged pain management. - The World Health Organization said in January 2025 that chronic diseases accounted for roughly 74% of global deaths in 2024. - The report pointed to growing use of opioid-sparing pain control, more outpatient and ambulatory surgeries, an aging population and increased use of ultrasound-guided interventions. - The report also highlighted broader ERAS, or enhanced recovery after surgery, protocols as a demand driver. - Expected market trends include greater use of ultrasound-guided catheter placement, multimodal pain management, continuous infusion techniques and longer-lasting regional anesthesia for ambulatory surgery.

Between the lines: - The forecast suggests pain management is shifting toward longer-duration, procedure-specific approaches instead of short-term medication alone. - North America held the largest market share in 2025, reflecting advanced healthcare infrastructure and broad adoption of newer pain management techniques. - Asia-Pacific is expected to be the fastest-growing region as healthcare spending, surgical volumes and medical facilities improve. - The report also covers South East Asia, Western Europe, Eastern Europe, South America and the Middle East and Africa, indicating where suppliers may look for expansion.

What's next: - Market growth will likely track how quickly hospitals and ambulatory centers adopt ultrasound-guided placement and continuous infusion workflows. - Expanding orthopedic surgery volumes and continued pressure to reduce opioid use should keep demand moving higher through 2030. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated technology and trend analysis.

The bottom line: - Continuous peripheral nerve block catheters are moving from a niche anesthesia tool to a broader pain-management growth market, with demand anchored by surgery volume, chronic disease and opioid-sparing care.